The Zhitong Finance App learned that French pharmaceutical giant Sanofi (SNY.US) released its first financial report since new CEO Belén Garijo (Belén Garijo) took office on Thursday. Although the company raised its full-year sales growth forecast due to the impressive performance of the blockbuster drug Dupixent, the market was disappointed by the contraction of R&D pipelines and the lack of strategic updates. The stock once fell more than 3% intraday in the Paris stock market.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.